BioSpace News Archive

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its third quarter earnings conference call will be webcast on Thursday, November 4, 2021 at 8:30 a.m. ET .

Epizyme today announced that the Company approved the grant of equity awards to a new employee with a grant date of October 1, 2021, as equity inducement awards outside of the Company’s 2013 Stock Incentive Plan and material to the employee’s acceptance of employment with the Company.

Second Genome presented preclinical data demonstrating that the Company’s novel microbiome-derived peptide, SG-3-0020, can upregulate key co-stimulatory and checkpoint molecules on T cells.

Exicure , Inc. today announced presentations in the following scientific conferences during the month of October: 17th International Congress on Neuronal Ceroid Lipofuscinosis (NCLs)

Rapid Therapeutics Science Laboratories (OTC: RTSL) (“Rapid Therapeutic’’ or the “Company”), a growth-oriented aerosol manufacturing company focused on delivery of non-psychoactive cannabinoid compounds, announces today that its shareholder update conference call scheduled for today following the close of market has been postponed.

Clinical Trial Design Announced for SEQUOIA-HCM, Phase 3 Clinical Trial of Aficamten Expected to Begin in Q4 Company Details Plan for Developing a Cardiovascular Franchise

Antios Therapeutics, Inc. today announced that Chief Executive Officer, Gregory Mayes and Chief Medical Officer and Co-Founder, Douglas Mayers , M.D., will participate alongside other leaders in HBV at the H.C. Wainwright 2nd Annual Hepatitis B Virus (HBV) Virtual Conference.

Enveric Biosciences today announced that Dr. Joseph Tucker , Chief Executive Officer of Enveric Biosciences, will participate in two upcoming October conferences: A.G.P.'s Biotech & Specialty Pharma Conference to be held virtually on Wednesday, October 13, 2021.

NeonMind Biosciences Inc. today announced that Robert Tessarolo , President and Chief Executive Officer, will present live at the KCSA Psychedelics Virtual Investor Conference.

MINDCURE invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com